MedPath

Clinical trial of sitafloxacin against non-gonococcal urethritis

Not Applicable
Conditions
on-gonococcal urethritis
Registration Number
JPRN-UMIN000004509
Lead Sponsor
PO CREC net
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have allegy to fluoroquinolones Patients with severe renal dysfunction Patients who have a history of epilepsy. Patients who have severe heart diseases including inchemic heart diseases or arrthythmia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Microbiological efficacy of STFX against causative bacteria(mMycoplasma genitalium,Chlamydaia trachomatis,Ureaplasma urealyticum)is investigated in non-gonococcal urethritis.
Secondary Outcome Measures
NameTimeMethod
Clinical efficacy of STFX is investigated in non-gonococcal urethritis. Validation of new nucleic acid amplification testing for detecting M.genitalium or U.urealyticum is validated. Antimicrobial susceptibility of M.genitalium or U.urealyticum Analysis of genome ralated to resistance to antimicrobials in M.genitalium
© Copyright 2025. All Rights Reserved by MedPath